1.
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in a...
by Boyd, M A
The Lancet (British edition), 2013, Vol.381 (9883), p.2091-2099
2.
Partner Notification for Chlamydial Infections Among Private Sector Clinicians in Seattle-King County: A Clinician and Patient Survey
by GOLDEN, M. R
Sexually transmitted diseases, 1999-10-01, Vol.26 (9), p.543-547
3.
Treatment and disease outcomes of migrants from low- and middle-income countries in the Australian HIV Observational Database cohort
by Tilley, Donna M.
AIDS care, 2015-11-02, Vol.27 (11), p.1410-1417
4.
Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort
by Law, W. Phillip
AIDS (London), 2004, Vol.18 (8), p.1169-1177
5.
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001
by Law, W. Phillip
AIDS (London), 2003, Vol.17 (15), p.2191-2199
6.
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis
by Boyd, M.A
AIDS (London), 2006, Vol.20 (7), p.1083-1085
7.
Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice
by Boyd, N A
Journal of clinical pathology, 1993-11, Vol.46 (11), p.1042-1045
8.
Anaphylaxis with intravenous gammaglobulin
by Mccluskey, D.R
The Lancet (British edition), 1990-10-06, Vol.336 (8719), p.874-874
9.
Popliteal Aneurysms
by Shucksmith, H. S
British Medical Journal, 1966-04, Vol.1 (5492), p.918-919
10.
Human B-cell isotype switching origins of IgE
by Looney, Timothy J., PhD
Journal of allergy and clinical immunology, 2015, Vol.137 (2), p.579-586.e7
11.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
by Balar, Arjun V, Dr
The Lancet (British edition), 2016, Vol.389 (10064), p.67-76
12.
Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury
by Kwon, Brian K
Journal of neurotrauma, 2010-04, Vol.27 (4), p.669-682
13.
Limited echocardiography–guided therapy in subacute shock is associated with change in management and improved outcomes
by Kanji, Hussein D., MD, MSc, MPH
Journal of critical care, 2014, Vol.29 (5), p.700-705
14.
Single B-cell deconvolution of peanut-specific antibody responses in allergic patients
by Hoh, Ramona A., PhD
Journal of allergy and clinical immunology, 2015, Vol.137 (1), p.157-167
15.
Maternal metabolites during pregnancy are associated with newborn outcomes and hyperinsulinaemia across ancestries
by Kadakia, Rachel
Diabetologia, 2018-11-27, Vol.62 (3), p.473-484
16.
Autism, language and communication in children with sex chromosome trisomies
by Bishop, Dorothy V M
Archives of disease in childhood, 2011-10, Vol.96 (10), p.954-959
17.
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study
by Campbell, Peter J
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1945-1953
18.
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label pha...
by Hillmen, Peter, Prof
The Lancet (British edition), 2015, Vol.385 (9980), p.1873-1883
19.
Benefits and harms of roflumilast in moderate to severe COPD
by Yu, Tsung
Thorax, 2014-07, Vol.69 (7), p.616-622
20.
Melanocortin-4 Receptor Signaling Is Required for Weight Loss after Gastric Bypass Surgery
by Hatoum, Ida J
The journal of clinical endocrinology and metabolism, 2012-06, Vol.97 (6), p.E1023-E1031
